MicroRNAs and Diabetic Complications
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Both Type 1 and Type 2 diabetes can lead to debilitating microvascular complications such as retinopathy, nephropathy and neuropathy, as well as macrovascular complications such as cardiovascular diseases including atherosclerosis and hypertension. Diabetic complications have been attributed to several contributing factors such as hyperglycemia, hyperlipidemia, advanced glycation end products, growth factors, and inflammatory cytokines/chemokines. However, current therapies are not fully efficacious and hence there is an imperative need for a better understanding of the molecular mechanisms underlying diabetic complications in order to identify newer therapeutic targets. microRNAs (miRNAs) are short non-coding RNAs that repress target gene expression via post-transcriptional mechanisms. Emerging evidence shows that they have diverse cellular and biological functions and play key roles in several diseases. In this review, we explore the role of miRNAs in the pathology of diabetic complications and also discuss the potential use of miRNAs as novel diagnostic and therapeutic targets for diabetic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292 · cited 1×
“first identified miRNA, lin-4 was found to play a critical role in controlling developmental timing by downregulating its target, lin-14, due to the antisense complementarity [13, 14].”
BackgroundMicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 1×
“Locked nucleic acid (LNA) modified antimiRNAs (antimiR) have been shown to be very effective for inhibiting miRNAs (36,83,84).”
BackgroundPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
Caporali, A., Meloni, M., Völlenkle, C., Bonci, D., Sala-Newby, G. B., Addis, R., Spinetti, G., Losa, S., Masson, R., Baker, A. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.952325 · Cited by 397
Saaddine, J. B. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.12.1740 · Cited by 377 · cited 1×
“DR is a very common microvascular complication of diabetes and also one of the leading causes of blindness in the USA [23, 24].”
BackgroundWang, X., Qian, R., Zhang, W., Chen, S., Jin, H., & Hu, R. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05057.x · Cited by 271
Villeneuve, L. M., Kato, M., Reddy, M. A., Wang, M., Lanting, L., & Natarajan, R. (2010) · Diabetes · doi:10.2337/db10-0208 · Cited by 186 · cited 5×
“miR-125b was upregulated in VSMC of diabetic mice relative to control mice, and could target the chromatin histone H3K9 methyltransferase Suv39h1 leading to increased expression of inflammatory gene expression in the diabetic cells (66,67).”
BackgroundInfluentialSelf-citation
Cited by
Circulating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy
Barutta, F., Tricarico, M., Corbelli, A., Annaratone, L., Pinach, S., Grimaldi, S., Bruno, G., Cimino, D., Taverna, D., Deregibus, M. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073798 · Cited by 317
Yang, D.-R., Wang, M.-Y., Zhang, C.-L., & Wang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359255 · Cited by 280
Zhu, H., & Leung, S. W. (2015) · Diabetologia · doi:10.1007/s00125-015-3510-2 · Cited by 271
Comparison of Analysis Tools for miRNA High Throughput Sequencing Using Nerve Crush as a Model
Metpally, R. P. R., Nasser, S., Malenica, I., Courtright, A., Carlson, E., Ghaffari, L., Villa, S., Tembe, W., & Van Keuren-Jensen, K. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00020 · Cited by 63
Metadata
- Authors
- Natarajan, R., Putta, S., & Kato, M.
- Venue
- Journal of Cardiovascular Translational Research
- Published
- 2012-05-03
- Volume
- 5
- Issue
- 4
- Pages
- 413-422
- ISSN
- 1937-5387 (ISSN-L)
- 1937-5395
- OpenAlex
- W2057933885
- Cited by
- 99
- References
- 9
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNAs and Diabetic Complications. https://app.cochat.ai/papers/10.1007/s12265-012-9368-5
- The paper
- Natarajan, R., Putta, S., & Kato, M. (2012). MicroRNAs and Diabetic Complications. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-012-9368-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.